Home / Peptides / NAD+ injections

NAD+ injections Dosage: What the Evidence Says (2026)

Not FDA-approved

Coenzyme sold alongside peptides. No approved injection; one small IV pharmacokinetic study.

Also called: NAD, nicotinamide adenine dinucleotide

Regulatory status (US)

There is no FDA-approved NAD+ injection. NAD and NADH are in FDA Category 1 (under evaluation), which allows pharmacy compounding under FDA's interim policy, but that is not an approval.

What it is

A coenzyme every cell uses for energy reactions. Not a peptide, but often sold and dosed alongside them.

Dosage

No established human dose. No FDA label or published dose-finding trial gives a dose for NAD+ injections. Numbers you see on seller sites or forums are not based on reviewed human studies, so we do not list them.

NAD+ injections reconstitution calculator

Enter your vial and your prescribed dose to see the units on a U-100 syringe.

–
Concentration–
Per 1 unit (0.01 mL)–
Volume per dose–
Doses per vial–

What human studies show

Safety

Questions

Is NAD+ injections FDA-approved?
There is no FDA-approved NAD+ injection. NAD and NADH are in FDA Category 1 (under evaluation), which allows pharmacy compounding under FDA's interim policy, but that is not an approval.
What dose of NAD+ injections has been studied?
There is no established human dose. A 2019 pilot gave 750 mg by IV over 6 hours to healthy men to study blood levels. There are no efficacy trials for injection under the skin.
How many units is my NAD+ injections dose?
Divide the mg in the vial by the mL of bacteriostatic water to get mg/mL, divide your dose in mg by that, and multiply by 100 for units on a U-100 syringe. The calculator on this page does it and draws the syringe.

Related

Sermorelin

The first 29 amino acids of GHRH. Former brand Geref was withdrawn in 2009; no product is marketed today.

BPC-157

15-amino-acid peptide studied mostly in animals. Not approved; no established human dose.

TB-500 (thymosin beta-4)

Name used for thymosin beta-4 and for a 7-amino-acid fragment of it. Not approved; no human dose data for the fragment.

GHK-Cu (copper peptide)

Copper-binding tripeptide used in skin care. Topical studies only; no human injection data.

Sources

  1. Grant et al. 2019: Pilot pharmacokinetics of IV NAD+ in healthy men
  2. FDA: 503A bulk drug substance categories (updated May 14, 2026, PDF)
  3. FDA 510(k) K212499: BD insulin syringes for U-100 insulin

Last checked 2026-11-16. How we pick and check sources: methodology.